SCHEMBL31706098

SCHEMBL31706098

O=C(O)c1nccc(N2CCN(C(=O)C3CC3)CC2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CKS1B P61024 1/20 0.55
▸ SKP1 P63208 1/20 0.55
▸ SKP2 Q13309 1/20 0.55
▸ ALDH1A1 P00352 3/20 0.47
▸ LSS P48449 2/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ IDE P14735 1/20 0.45
▸ GBA1 P04062 1/20 0.44
▸ MAPT P10636 4/20 0.44
▸ TP53 P04637 4/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ MAP4K4 O95819 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31705458 0.88 CKS1B (0.44) CKS1BSKP1SKP2ALDH1A1LSS
Lithium Ion SCHEMBL31705926 0.87 CKS1B (0.50) CKS1BSKP1SKP2ALDH1A1LSS
Lithium Ion SCHEMBL31706628 0.87 CKS1B (0.50) CKS1BSKP1SKP2ALDH1A1LSS
SCHEMBL31705550 0.85 CKS1B (0.48) CKS1BSKP1SKP2ALDH1A1LSS
SCHEMBL31705275 0.85 CKS1B (0.48) CKS1BSKP1SKP2ALDH1A1LSS
SCHEMBL31704996 0.81 CKS1B (0.55) CKS1BSKP1SKP2ALDH1A1GBA1
SCHEMBL21880062 0.79 KMO (0.53) ALDH1A1GBA1SORD
SCHEMBL31705731 0.78 HTR2B (0.42) CKS1BSKP1SKP2ALDH1A1TDP1
SCHEMBL31705670 0.78 MAP4K4 (0.52) ALDH1A1GBA1MAPTNPC1RAB9A
Lithium Ion SCHEMBL31704621 0.76 LSS (0.41) CKS1BSKP1SKP2ALDH1A1LSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215110-A1 NEW AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS SOS1 INHIBITORS LES LABORATOIRES SERVIER (FR) 2025-10-16 — — WO disclosed
Send feedback